ERBB2 and glioblastoma: CAR-T cells targeting the antigens Interleukin-13 receptor alpha 2 (IL13R2), human epidermal growth factor receptor 2 (HER2), and epidermal growth factor receptor variant III (EGFRvIII) have been produced in glioblastoma [146].